Oncothyreon, Merck KGaA deal

ONTY (formerly Biomira Inc.) received a $5 million milestone payment from MRK under a 2001 deal to develop and market ONTY's Stimuvax cancer vaccine (see BioCentury, Aug. 13 & May 7, 2001). The paym...